169 related articles for article (PubMed ID: 31209680)
1. Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Bergeron A; Kostenkova K; Selman M; Murakami HA; Owens E; Haribabu N; Arulanandam R; Diallo JS; Crans DC
Biometals; 2019 Jun; 32(3):545-561. PubMed ID: 31209680
[TBL] [Abstract][Full Text] [Related]
2. The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes.
Zhang Y; Yang XD; Wang K; Crans DC
J Inorg Biochem; 2006 Jan; 100(1):80-7. PubMed ID: 16321441
[TBL] [Abstract][Full Text] [Related]
3. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
4. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
5. 51V solid-state NMR and density functional theory studies of vanadium environments in V(V)O2 dipicolinic acid complexes.
Bolte SE; Ooms KJ; Polenova T; Baruah B; Crans DC; Smee JJ
J Chem Phys; 2008 Feb; 128(5):052317. PubMed ID: 18266434
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Selman M; Rousso C; Bergeron A; Son HH; Krishnan R; El-Sayes NA; Varette O; Chen A; Le Boeuf F; Tzelepis F; Bell JC; Crans DC; Diallo JS
Mol Ther; 2018 Jan; 26(1):56-69. PubMed ID: 29175158
[TBL] [Abstract][Full Text] [Related]
7. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
9. Aerobic oxidation of pinacol by vanadium(V) dipicolinate complexes: evidence for reduction to vanadium(III).
Hanson SK; Baker RT; Gordon JC; Scott BL; Sutton AD; Thorn DL
J Am Chem Soc; 2009 Jan; 131(2):428-9. PubMed ID: 19140782
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and cell viability test of six vanadyl complexes with acetylacetonate derivatives.
Sgarbossa S; Diana E; Marabello D; Deagostino A; Cadamuro S; Barge A; Laurenti E; Gallicchio M; Boscaro V; Ghibaudi E
J Inorg Biochem; 2013 Nov; 128():26-37. PubMed ID: 23911568
[TBL] [Abstract][Full Text] [Related]
11. 4-amino- and 4-nitrodipicolinatovanadium(V) complexes and their hydroxylamido derivatives: synthesis, aqueous, and solid-state properties.
Smee JJ; Epps JA; Teissedre G; Maes M; Harding N; Yang L; Baruah B; Miller SM; Anderson OP; Willsky GR; Crans DC
Inorg Chem; 2007 Nov; 46(23):9827-40. PubMed ID: 17941629
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
Crans DC
J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
[TBL] [Abstract][Full Text] [Related]
13. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.
Rehder D; Costa Pessoa J; Geraldes CF; Castro MC; Kabanos T; Kiss T; Meier B; Micera G; Pettersson L; Rangel M; Salifoglou A; Turel I; Wang D
J Biol Inorg Chem; 2002 Apr; 7(4-5):384-96. PubMed ID: 11941496
[TBL] [Abstract][Full Text] [Related]
14. Vanadium(V) complexes with hydrazides and their spectroscopic and biological properties.
Sultan S; Ashiq U; Jamal RA; Mahroof-Tahir M; Shaikh Z; Shamshad B; Lateef M; Iqbal L
Biometals; 2017 Dec; 30(6):873-891. PubMed ID: 28994011
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
16. Vanadium(IV)-chlorodipicolinate inhibits 3T3-L1 preadipocyte adipogenesis by activating LKB1/AMPK signaling pathway.
Zhang L; Huang Y; Liu F; Zhang F; Ding W
J Inorg Biochem; 2016 Sep; 162():1-8. PubMed ID: 27318173
[TBL] [Abstract][Full Text] [Related]
17. Complexes of N-hydroxyethyl-N-benzimidazolylmethylethylenediaminediacetic acid with group 12 metals and vanadium-Synthesis, structure and bioactivity of the vanadium complex.
Habala L; Bartel C; Giester G; Jakupec MA; Keppler BK; Rompel A
J Inorg Biochem; 2015 Jun; 147():147-52. PubMed ID: 25920686
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and crystal structure of 2-amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-κ³O²,N,O⁶)vanadate(V) and its conversion to nanostructured V₂O₅.
Hejrani-Dalir A; Tabatabaee M; Sheibani A
Acta Crystallogr C Struct Chem; 2015 Feb; 71(Pt 2):89-92. PubMed ID: 25652272
[TBL] [Abstract][Full Text] [Related]
19. Vanadium-Flavonoid Complexes: A Promising Class of Molecules for Therapeutic Applications.
Selvaraj S; Krishnan UM
J Med Chem; 2021 Sep; 64(17):12435-12452. PubMed ID: 34432460
[TBL] [Abstract][Full Text] [Related]
20. In vitro apoptosis-induction, antiproliferative and BSA binding studies of a oxidovanadium(V) complex.
Kongot M; Dohare N; Reddy DS; Pereira N; Patel R; Subramanian M; Kumar A
J Trace Elem Med Biol; 2019 Jan; 51():176-190. PubMed ID: 30466929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
